-
HCPLive Under 5 Audio Recap: Week of 04/06
- 2025/04/13
- 再生時間： 4 分
- ポッドキャスト
-
サマリー
あらすじ・解説
Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 Healthcare Headlines for March 31-April 6, 2025:
Cedars-Sinai Study Finds AI Tool Could Improve Care in Virtual Urgent Care Settings
A Cedars-Sinai study suggests AI tools may enhance guideline adherence and decision-making quality in virtual urgent care, though clinician oversight remains essential.
FDA Accepts Biologics License Application for ONS-5010 for Wet AMD
The FDA has accepted a resubmitted BLA for ONS-5010, a proposed ophthalmic formulation of bevacizumab for wet AMD, advancing it toward potential approval.
Socioeconomic Status Impacts Pediatric Preemptive Kidney Transplant Rates, Study Finds
A retrospective study linked lower socioeconomic status to reduced access to preemptive kidney transplants in pediatric patients, underscoring ongoing disparities in care.
FDA Clears Dexcom G7 15 Day CGM System
The FDA has cleared the Dexcom G7 CGM system for 15-day use in adults, offering extended wear and continued improvements in diabetes monitoring technology.
Icotrokinra Clears Skin Among 75% of Adolescents with Plaque Psoriasis
New phase 3 data show once-daily icotrokinra improves skin clearance and maintains a favorable safety profile in adolescents with moderate-to-severe plaque psoriasis.
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 Healthcare Headlines for March 31-April 6, 2025:
Cedars-Sinai Study Finds AI Tool Could Improve Care in Virtual Urgent Care Settings
A Cedars-Sinai study suggests AI tools may enhance guideline adherence and decision-making quality in virtual urgent care, though clinician oversight remains essential.
FDA Accepts Biologics License Application for ONS-5010 for Wet AMD
The FDA has accepted a resubmitted BLA for ONS-5010, a proposed ophthalmic formulation of bevacizumab for wet AMD, advancing it toward potential approval.
Socioeconomic Status Impacts Pediatric Preemptive Kidney Transplant Rates, Study Finds
A retrospective study linked lower socioeconomic status to reduced access to preemptive kidney transplants in pediatric patients, underscoring ongoing disparities in care.
FDA Clears Dexcom G7 15 Day CGM System
The FDA has cleared the Dexcom G7 CGM system for 15-day use in adults, offering extended wear and continued improvements in diabetes monitoring technology.
Icotrokinra Clears Skin Among 75% of Adolescents with Plaque Psoriasis
New phase 3 data show once-daily icotrokinra improves skin clearance and maintains a favorable safety profile in adolescents with moderate-to-severe plaque psoriasis.